Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness

Transplant International

Volumn 18, Issue 6, 2005, Pages 735-742

  Hillebrands, Jan Luuk ^a   Van Dam, Joanne G ^b   Onuta, Geanina ^a   Klatter, Flip A ^a   Grauls, Gert ^b   Bruggeman, Cathrien A ^b   Rozing, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Aorta transplantation; Chronic transplant dysfunction; Cytomegalovirus; Rat; Transplant arteriosclerosis

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DONOR; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; RAT STRAIN; RECIPIENT; TIME; VIRUS TRANSMISSION; ANIMAL; AORTA; BROWN NORWAY RAT; SPECIES DIFFERENCE; TRANSPLANTATION; WISTAR FURTH RAT;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; MALE; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED BN; RATS, INBRED WF; SPECIES SPECIFICITY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 23244454122     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00139.x     Document Type: Article

References (25)

1. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation 1989; 80: III100.
2. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998; 17: 744.
3. Kouwenhoven EA, IJzermans JN, de Bruin RW. Etiology and pathophysiology of chronic transplant dysfunction. Transpl Int 2000; 13: 385.
4. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant 2004; 4: 169.
5. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
6. Fateh-Moghadam S, Bocksch W, Wessely R, Jager G, Hetzer R, Gawaz M. Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation 2003; 76: 1470.
7. Valantine HA, Gao SZ, Menon SG, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 1999; 100: 61.
8. Weill D. Role of cytomegalovirus in cardiac allograft vasculopathy. Transpl Infect Dis 2001; 3(Suppl. 2): 44.
9. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Häyry P. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler Thromb 1991; 11: 671.
10. Lemström K, Aho PT, Bruggeman CA, Häyry P. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor- β1 in rat aortic allografts: possible mechanism for cytomegalovirus- enhanced graft arteriosclerosis. Arterioscler Thromb 1994; 14: 2043.
11. Li F, Grauls G, Yin M, Bruggeman CA. Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts. Transpl Int 1996; 9: S340.
12. Lemström KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Häyry P. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92: 549.
13. Bruning JH, Persoons M, Lemström K, Stals FS, De Clercq E, Bruggeman CA. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transpl Int 1994; 7: S365.
14. Li F, Yin M, van Dam JG, Grauls G, Rozing J, Bruggeman CA. Cytomegalovirus infection enhances the neointima formation in rat aortic allografts. Effect of major histocompatibility complex class I and class II antigen differences. Transplantation 1998; 65: 1298.
15. Orloff SL, Streblow DN, Soderberg-Naucler C, et al. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 2002; 73: 679.
16. Hillebrands JL, Klatter FA, van den Hurk BMH, Popa ER, Nieuwenhuis P, Rozing J. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107: 1411.
17. Bruggeman CA, Meijer H, Dormans PH, Debie WM, Grauls GE, van Boven CP. Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 1982; 73: 231.
18. Bruggeman CA, Grauls G, van Boven CPA. Susceptibility of peritoneal macrophages to rat cytomegalovirus infection. FEMS Microbiol Lett 1985; 27: 263.
19. Bruggeman CA, Mijer H, Bosman F, van Boven CPA. Biology of rat cytomegalovirus infection. Intervirology 1985; 24: 1.
20. Bruning JH, Bruggeman CA, van Boven CP, Breda Vriesman PJ. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model. Transplantation 1986; 41: 695.
21. Bruning JH, Debie WH, Dormans PH, Meijer H, Bruggeman CA. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 1987; 94: 55.
22. Beuken E, Slobbe R, Bruggeman CA, Vink C. Cloning and sequence analysis of the genes encoding DNA polymerase, glycoprotein B, ICP18.5 and major DNA-binding protein of rat cytomegalovirus. J Gen Virol 1996; 77: 1559.
23. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of experimental arterial allograft. Transplantation 1995; 60: 414.
24. van der Werf N, Hillebrands JL, Klatter FA, Bos I, Bruggeman CA, Rozing J. Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin Dev Immunol 2003; 10: 153.
25. van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid- organ transplantation. Clin Infect Dis 2001; 33(Suppl. 1): S32.